Regulation of Phosphatidylserine Transbilayer Redistribution by Store-operated Ca2+ Entry

ROLE OF ACTIN CYTOSKELETON*

Corinne Kunzelmann-MarcheDagger §, Jean-Marie FreyssinetDagger §, and M. Carmen MartínezDagger §||**

From the Dagger  Institut d'Hématologie et d'Immunologie, Université Louis Pasteur, Faculté de Médecine, 4 rue Kirschleger, Strasbourg 67085, France and the § Unité 143 INSERM, Hôpital de Bicêtre, Le Kremlin-Bicêtre 94275, France

Received for publication, August 30, 2000, and in revised form, October 31, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The phosphatidylserine transmembrane redistribution at the cell surface is one of the early characteristics of cells undergoing apoptosis and also occurs in cells fulfilling a more specialized function, such as the phosphatidylserine-dependent procoagulant response of platelets after appropriate activation. Although an increase in cytoplasmic Ca2+ is essential to trigger the remodeling of the plasma membrane, little is known about intracellular signals leading to phosphatidylserine externalization. Here, the role of store-operated Ca2+ entry on phosphatidylserine exposure was investigated in human erythroleukemia HEL cells, a pluripotent lineage with megakaryoblastic properties. Ca2+ entry inhibitors (SKF-96365, LaCl3, and miconazole) inhibited store-operated Ca2+ entry in A23187- or thapsigargin-stimulated cells and reduced the degree of phosphatidylserine externalization concomitantly, providing evidence for a close link between the two processes. In cells pretreated with cytochalasin D, an agent that disrupts the microfilament network of the cytoskeleton, store-operated Ca2+ entry and phosphatidylserine externalization at the cell surface were inhibited. In a context where most of the key actors remain to be identified, these results provide evidence for the implication of both store-operated Ca2+ entry and cytoskeleton architectural organization in the regulation of phosphatidylserine transbilayer migration.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Changes in the cytoplasmic free Ca2+ concentration ([Ca2+]i)1 constitute one of the main pathways by which information is transferred from extracellular signals into various intracellular compartments (1, 2). The induction of receptor-mediated cytosolic Ca2+ signals involves two interdependent and closely coupled events: (i) a rapid and transient release of Ca2+ stored in the endoplasmic reticulum, (ii) followed by slowly developing extracellular Ca2+ entry (1, 3, 4).

In many cell types, including human platelets, depletion of the intracellular Ca2+ stores induces entry of Ca2+ across the plasma membrane (5), referred to as capacitative or store-operated Ca2+ entry (SOCE) (6). Cell stimulation by Ca2+-mobilizing agents triggers the migration of phosphatidylserine (PS) to the exoplasmic leaflet (7), an aminophospholipid sequestered in the inner leaflet of the plasma membrane of nonstimulated cells (8), followed by the shedding of small vesicles released from the plasma membrane (9, 10). These microparticles contain surface proteins and cytoplasmic components of the original cell. Thus, shedding of PS-expressing microvesicles appears to be closely associated with cell surface externalization of PS (11). The exposure of PS is a key step for the hemostatic response (11) and becomes a recognition signal for the phagocytosis of apoptotic cells (12). It has been demonstrated that exposure of PS in erythrocytes and platelets (13) as well as during apoptosis (14) is dependent on extracellular Ca2+ and that a continuously elevated [Ca2+]i level may be necessary to sustain the externalization process (15). Furthermore, Ca2+ influx across the plasma membrane and maximal exposure of aminophospholipids seem necessary for membrane microparticle formation in platelets (10). In a previous study (16), we have shown that an alteration of SOCE is correlated with a defective exposure of PS in cells isolated from a patient with an extremely rare inherited disorder of PS externalization, the Scott syndrome. Nevertheless, little information regarding the upstream and downstream intracellular signals leading to PS externalization or phospholipid scrambling has been provided. Although several hypotheses have been proposed regarding direct or indirect coupling mechanisms of the endoplasmic reticulum and the plasma membrane (17, 18), little is known about the intracellular signals governing SOCE or the Ca2+ channels mediating this particular form of Ca2+ entry. Recently, Rosado et al. (19) suggested that SOCE is mediated by actin cytoskeleton in human platelets.

To examine the significance of SOCE on PS externalization, we have combined the detection of PS exposure and the measurement of [Ca2+]i in human erythroleukemia (HEL) cells, a megakaryoblastic cell line expressing specific receptors found in platelets (20, 21). We report here that SOCE regulates PS externalization, and cytoskeletal elements modulate both SOCE and PS transmembrane migration. The present study opens a new field of investigation of possible relationships between Ca2+ signaling and the remodeling of the plasma membrane.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- RPMI 1640 and fetal calf serum were from Life Technologies (Paisley, UK), and other cell culture reagents were from BioWhittaker (Walkersville, MD). Ca2+ ionophore A23187 and SKF-96365 (1-[beta -[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole hydrochloride) were obtained from Calbiochem (La Jolla, CA). Fluo-3/acetoxymethyl ester (Fluo-3) was from Molecular Probes (Eugene, OR) and thapsigargin (TG) from Alexis Corp. (San Diego, CA). Miconazole, cytochalasin D (CytD) and LaCl3 were products from Sigma Chemical Co. (St. Louis, MO). Human blood coagulation factors Xa and prothrombin, annexin V and annexin VFITC, were, respectively, the same as those previously used in our laboratory (22, 23). Factor V was purchased from Diagnostica Stago (Asnières, France) and chromogenic substrate H-D-phenylalanyl-L-pipecolyl-L-arginine-p-nitroaniline-dihydrochloride (Chromozyme TH) from Roche Diagnostics (Mannheim, Germany).

Cell Culture-- HEL cells constitute a continuous megakaryoblastic cell line expressing markers such as thrombopoietin, thrombin receptors, and glycoprotein IIb/IIIa, with some of them being found in platelets (24-26). HEL were seeded at 1 × 105 cells/ml and cultured in RPMI 1640 (free Ca2+ concentration = 0.4 mM) supplemented with L-glutamine (2 mM), 1% (v/v) nonessential amino acids, sodium pyruvate (1 mM), gentamicin (20 µg/ml), and 10% (v/v) heat-inactivated fetal calf serum, at 37 °C in humidified 5% CO2 atmosphere. All experiments were performed with maximal concentrations of inhibitors at which no cytotoxicity was observed.

Assessment of PS Exposure by Prothrombinase Functional Assay-- Cell suspensions were centrifuged at 600 × g for 5 min, washed once in Hanks' balanced salt solution, and resuspended at the concentration of 1 × 105 cells/ml. Cells were preincubated at 37 °C for 15 min with 3 and 10 µM SKF-96365 or 10 µM miconazole and for 30 min with 10 µM CytD. Cells were then stimulated with 2 µM ionophore A23187 for 10 min at 37 °C, and centrifuged at 12,000 × g for 2 min to separate the microparticle-containing supernatant from the corresponding cells. Procoagulant PS exposure in stimulated cells and derived microparticles was detected, in the presence of 1 mM CaCl2, using a human prothrombinase assay in which this phospholipid is the rate-limiting parameter promoting the activation of prothrombin by factor Xa in the presence of factor Va (27). Thrombin generated by the assembled prothrombinase complex was measured using a chromogenic assay, as described elsewhere (23).

Measurements of [Ca2+]i by Flow Cytometry-- HEL cells were used at 106 cells/ml. They were loaded with 3 µM Fluo-3 for 30 min at room temperature and then washed twice in RPMI 1640 medium supplemented with CaCl2 (final Ca2+ concentration ~ 1 mM) and resuspended at the same concentration (106 cells/ml, 500 µl/analysis). To study Ca2+ release and Ca2+ entry separately, the experiments were performed in the presence of EGTA (1 mM), able to chelate the totality of Ca2+ in RPMI 1640 medium. Cells were then stimulated by the different agents, and CaCl2 was added to restore an extracellular Ca2+ concentration of ~1 mM, allowing capacitative Ca2+ entry. Fluo-3 fluorescence was monitored using a FACScan Becton-Dickinson flow cytometer and the CELLQuest software. A baseline value was obtained for each sample by fluorescence measurement for 30 s before addition of pharmacologic agents. Collection was immediately resumed, then terminated after additional 5 min (~50,000 events). Fluo-3 fluorescence was expressed in arbitrary fluorescence intensity units and plotted as FL-1 versus time. To convert these values into absolute [Ca2+]i, calibration was performed at the end of each experiment. [Ca2+]i was calculated using the equation: [Ca2+]i = Kd[(F - Fmin)/(Fmax - F)], where Kd is the dissociation constant of the Ca2+·Fluo-3 complex (400 nM) (28). Fmax represents the maximum fluorescence (obtained by treating cells with 10 µM A23187), and Fmin corresponds to the minimum fluorescence (obtained for ionophore-treated cells in the presence of 1 mM EGTA). F is the actual sample fluorescence. Fluorescence intensities were expressed as the increase in fluorescence with respect to baseline fluorescence intensity before stimulation.

Flow Cytometry Analysis-- PS probing was achieved using annexin VFITC (140 nM final concentration). Incubation at room temperature was allowed to proceed for 10 min before data acquisition. In some cases, cells were activated in the presence of 1 mM CaCl2 with 2 µM Ca2+ ionophore A23187 for 10 min at 37 °C before addition of annexin VFITC. In another set of experiments, cell-derived microparticles were separated from activated cells by centrifugation at 400 × g for 5 min at room temperature. Under this condition, 100% of cells were eliminated as well as the larger cell fragments. Annexin VFITC wad added to the microparticle-containing supernatant. Samples were analyzed using the FACScan flow cytometer. The forward light scatter and fluorescence channels were set at logarithmic gains. The forward light scatter setting was E-01. The identification of cell and microparticle populations was performed as previously already described (29).

Statistical Analysis-- Results were expressed as mean ± S.E. of at least four separate experiments performed at different culture stages and/or passages, with no obvious difference attributable to the culture conditions. Paired Student's t test was used for the statistical analysis. A p value of <0.05 was considered significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Changes of [Ca2+]i-- To investigate the changes of [Ca2+]i, HEL cells were loaded with the Ca2+-binding fluorophore Fluo-3, and emission fluorescence shifts were monitored by flow cytometry. As shown in Fig. 1, stimulation by the Ca2+-ionophore A23187 evoked Ca2+ signal with two characteristic phases: a rapid rise in [Ca2+]i within a few seconds, followed by a sustained phase of elevated [Ca2+]i lasting several minutes, which resembles Ca2+ entry. To determine whether this sustained Ca2+ phase reflected Ca2+ entry, cells were treated with SKF-96365, an agent known to block store-operated Ca2+ channels (30) and other Ca2+ channels. SKF-96365 by itself significantly increased (p < 0.05) basal fluorescence intensity, [Ca2+]i basal values being 43 ± 5 nM, 87 ± 10, and 103 ± 27 nM in the absence and in the presence of 3 and 10 µM SKF-96365, respectively. At 1 µM, SKF-96365 did not significantly modify Ca2+ response induced by calcium ionophore A23187 (Table I). As illustrated in Fig. 1, SKF-96365 treatment reduced the amplitude of the [Ca2+]i sustained phase in HEL cells stimulated with A23187 in the presence of external Ca2+ in the medium (~1 mM). SKF-96365 was responsible for a dose-dependent inhibition of Ca2+ entry between 3 and 10 µM, with reductions of ~13 and 20%, respectively (Table I). Above 10 µM SKF-96365, cytotoxicity precluded further observations (not shown).



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of SKF-96365 on Ca2+ ionophore-induced response. Representative traces of Ca2+ signal induced by 2 µM Ca2+ ionophore A23187 in the presence of Ca2+ in the external medium (1 mM), in the absence or in the presence of SKF-96365 (10 µM). Note that SKF-96365 reduced the amplitude of the sustained elevation of [Ca2+]i seen in A23187-stimulated cells. Solid lines represent the averaged and smoothed data as a function of time.


                              
View this table:
[in this window]
[in a new window]
 
Table I
A23187-induced Ca2+ response in HEL cells
Cells were preincubated with the Ca2+ entry inhibitors SKF-96365 (1, 3, and 10 µM), LaCl3 (30 µM), or miconazole (10 µM) in the presence of 1 mM CaCl2 in the external medium and activated with 2 µM A23187. Results are expressed as percentage of the A23187-induced Ca2+ response ± S.E. in the absence of inhibitors, which was 378 ± 33 arbitrary fluorescence units. Data are representative of four to six experiments.

In platelets, A23187 has been reported to induce Ca2+ release from intracellular stores, and after sustained depletion, voltage-independent Ca2+ influx across the plasma membrane becomes activated (7). To confirm which is the pathway affected by SKF-96365 in HEL cells, the same experiments were repeated in the presence of LaCl3, an inhibitor of divalent cationic channels (31), and miconazole, an imidazole compound able to inhibit SOCE (32). No significant difference was detected in the basal fluorescence intensity after LaCl3 treatment ([Ca2+]i basal values were 43 ± 6 and 48 ± 12 nM, in the absence and in the presence of LaCl3, respectively). However, miconazole increased significantly (p < 0.05) the basal fluorescence intensity ([Ca2+]i basal value was 76 ± 10 nM). As illustrated in Table I, LaCl3 (30 µM) or miconazole (10 µM) treatment reduced Ca2+ entry by ~20 and 15%, respectively. Collectively, these data suggest that the sustained phase of elevated [Ca2+]i induced by A23187 in HEL cells is due to SOCE activation.

Effect of Ca2+ Entry Inhibitors on PS Externalization-- In the absence of stimulation (Fig. 2A), HEL cells and the corresponding supernatants showed a basal PS-dependent prothrombinase activity of 0.01 ± 0.005 and 0.02 ± 0.008 NIH units of thrombin generated per min/ml/2 × 105 cells, respectively. Following treatment with 3 and 10 µM SKF-96365, these activities increased ~2-fold, testifying to a weak ability of this agent to perturb PS asymmetric distribution by itself. After Ca2+ ionophore treatment, prothrombinase activity was ~12-fold and ~3.5-fold enhanced in cells and corresponding supernatants, respectively. SKF-96365 significantly (p < 0.05) affected the development of prothrombinase activity induced by Ca2+ ionophore with an inhibition of ~40 and 48% in the presence of 3 and 10 µM SKF-96365, respectively. The same behavior was observed in the corresponding supernatants.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   Extent of PS exposure revealed by prothrombinase activity measured in HEL cells and corresponding supernatants. Cells were preincubated with SKF-96365 (3 and 10 µM, A) or miconazole (10 µM, B) for 15 min at 37 °C and were either nonstimulated or stimulated by 2 µM A23187 for 10 min at 37 °C, in the presence of 1 mM external CaCl2. Data are expressed as mean ± S.E. of five to six independent experiments (each with duplicate samples). *, p < 0.05.

Prothrombinase activity measurements were also performed in the presence of LaCl3 and miconazole. LaCl3 interfered in this assay, probably because it was able to form a coordinate complex with PS (33), making the latter inaccessible for the assembly of the coagulation factors at the cell surface. As shown in Fig. 2B, miconazole also decreased the development of prothrombinase activity induced by A23187 in HEL cells; however, the inhibition (34%, p < 0.05) was lower than that observed with 10 µM SKF-96365. Prothrombinase activity was reduced accordingly in the corresponding supernatants.

To establish whether microparticles from HEL cells released after A23187 treatment bear exposed PS at their surface, cells and/or corresponding supernatants were incubated with annexin VFITC, a widely used probe for PS (Fig. 3). Unstimulated HEL cells presented a basal level of fluorescence concerning ~75% of the cells (Fig. 3B, upper left region), testifying to the probable weak binding of annexin VFITC to various membrane components, including phospholipids other than PS, because interaction may be favored in the presence of Ca2+ at concentration as high as 1 mM (34). The remaining ~25% of events in the upper right region of Fig. 3B likely represents spontaneously activated and/or apoptotic cells expressing a proportion of PS at their surface, with the corresponding PS-positive (i.e. annexin VFITC-positive) microparticle population in the lower right region of Fig. 3E. In agreement with prothrombinase assay (Figs. 2A, 2B, and 4C), A23187 induced extensive PS exposure in cells (Fig. 3C), as shown by the marked shift of ~99% of the cells to the upper right region, i.e. that of the highest fluorescence intensities. This was indeed also the case for microparticle shedding (Fig. 3F), as evidenced by the large proportion of annexin VFITC-positive events in the lower right region (91 ± 2%). Hence, microparticles virtually stemming from activated cells bear accessible PS and are therefore procoagulant.



View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   Assessment of PS exposure in nonstimulated and stimulated HEL cells and derived microparticles by flow cytometry. PS externalization was revealed through the binding of 140 nM annexin VFITC. When stimulated, cells were incubated with 2 µM A23187 for 10 min at 37 °C, in the presence of 1 mM external CaCl2. Derived microparticles were separated from activated cells by centrifugation as described under "Experimental Procedures." Top panels, HEL cells and derived microparticles; bottom panels, HEL-derived microparticles; A, D, unstimulated; B, E, unstimulated + annexin VFITC; C, F, stimulated + annexin VFITC. Dot plots are representations of forward light scatter versus annexin VFITC fluorescence signals. Cell (upper region) and microparticle (lower region) populations were distinguished according to size reflected by forward light scatter signals. Fluorescence thresholds were set on the basis of respective autofluorescence signals, i.e. in the absence of annexin VFITC.



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of SKF-96365 on TG-evoked Ca2+ response. A, representative traces showing the effect of SKF-96365 (10 µM) on Ca2+ signal induced by 1 µM TG in the presence of EGTA, and the subsequent reintroduction of 1 mM CaCl2 in the external medium. Solid lines represent the averaged and smoothed data as a function of time. It has to be emphasized that SKF-96365 reduced the amplitude of the sustained elevation of [Ca2+]i observed in TG-stimulated cells. B, histograms showing the effect of SKF-96365 (3 and 10 µM) on the increase in Fluo-3 fluorescence evoked by TG in the presence of EGTA, and the subsequent addition of 1 mM CaCl2 in the external medium. Results are expressed as the mean of fluorescence ± S.E. of five experiments. *, p < 0.05.

TG-evoked Ca2+ Influx-- To establish whether the Ca2+ entry inhibitors affect Ca2+ release from intracellular stores or SOCE, HEL cells were initially stimulated with TG (1 µM), an inhibitor of reticulum endoplasmic Ca2+-ATPases, in the presence of EGTA (1 mM) in the extracellular medium (Fig. 4A). Under these conditions, the addition of 1 µM TG to Fluo-3-loaded cells evoked a transient and slow elevation in [Ca2+]i due to the release of Ca2+ from internal stores. Subsequent reintroduction of 1 mM CaCl2 in the external medium induced a sustained increase in [Ca2+]i, indicative of SOCE. At 1 µM, SKF-96365 had no effect on CaCl2-evoked response in TG-exposed cells (not shown). Relative to controls, the magnitude of SOCE upon CaCl2 addition was significantly reduced (~20%) in 3 or 10 µM SKF-96365-treated cells after stimulation with 1 µM TG (Fig. 4, A and B).

As shown above with SKF-96365, both LaCl3 and miconazole did not affect Ca2+ release from intracellular stores (Table II). After CaCl2 reintroduction, these inhibitors were able to significantly reduce SOCE (~19 and 12%, respectively).


                              
View this table:
[in this window]
[in a new window]
 
Table II
Effect of LaCl3, and miconazole on TG-evoked Ca2+ entry
Cells were preincubated for 15 min with LaCl3 (30 µM) or miconazole (10 µM) in the presence of EGTA in the external medium, then stimulated with 1 µM TG and subsequent reintroduction of CaCl2 (~1 mM, final concentration). Results are expressed as percentage of the TG-evoked response ± S.E. in the absence of inhibitors, which was 189 ± 22 arbitrary fluorescence units, and of the CaCl2-evoked response ± S.E. of TG-pretreated cells in the absence of inhibitors, which was 212 ± 19 arbitrary fluorescence units. Data are representative of four to seven experiments.

Disruption of the Actin Cytoskeleton Inhibits SOCE and PS Exposure in HEL Cells-- HEL cells were preincubated with 10 µM CytD, a widely used membrane-permeant inhibitor of actin polymerization, which binds to the barbed end of actin filaments (35). Under these conditions, basal values of [Ca2+]i were 50 ± 5 and 133 ± 34 nM, in the absence and in the presence of CytD, respectively, but this difference was not statistically significant. CytD reduced A23187-induced Ca2+ signal by ~20% (Fig. 5A). As illustrated in Fig. 5B, in the presence of EGTA, CytD reduced TG-evoked Ca2+ signal (by 32%, p < 0.05), indicating that Ca2+ stores are affected by the inhibition of actin polymerization. In addition, CytD reduced CaCl2-evoked response in TG-exposed cells (by 21%, p < 0.01).



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   The significance of actin cytoskeleton integrity on Ca2+ entry and externalization of PS. A, histograms showing the decrease in Fluo-3 fluorescence in HEL cells stimulated by A23187 (2 µM) in the presence versus absence of cytochalasin D (CytD, 10 µM). Cells were incubated for 30 min with CytD or not prior activation by Ca2+ ionophore. B, cells were preincubated with CytD in the presence of EGTA in the external medium, with subsequent reintroduction of CaCl2 where indicated, in the continuous presence of TG. Results are expressed as the mean of fluorescence ± S.E. of five to seven experiments. C, prothrombinase activity measured in HEL cells and corresponding supernatants. Cells were preincubated with CytD (10 µM) for 30 min at 37 °C and were either nonstimulated or stimulated by 2 µM A23187 for 10 min at 37 °C, in the presence of 1 mM external CaCl2. Data are representative of seven independent experiments (each with duplicate samples). *, p < 0.05; **, p < 0.01.

Fig. 5C shows the effect of CytD on PS externalization at the HEL cell membrane surface. CytD by itself did not significantly modify prothrombinase activity. However, CytD treatment reduced A23187-induced PS exposure by 38% (p < 0.05), suggesting that PS transmembrane movements are, at least in part, modulated by actin polymerization. The decrease of prothrombinase activity in the corresponding supernatants was weaker.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The present study provides evidence that PS externalization is related to Ca2+ entry in HEL cells, and more specifically to a particular way of Ca2+ entry, referred to as SOCE. In addition, we show that both events, SOCE and PS exposure, are regulated, at least in part, by actin cytoskeleton.

Like platelets and many other nonexcitable cells (5, 36), HEL cells undergo SOCE, as observed here after CaCl2-induced response in TG-treated cells. Three common inhibitors of SOCE, SKF-96365, LaCl3, and miconazole (30-32, 37), partially inhibited capacitative Ca2+ entry in HEL cells without affecting Ca2+ release from intracellular stores. At the actual concentrations used, miconazole inhibited less efficiently A23187- and TG-induced Ca2+ entry compared with SKF-96365 and LaCl3. However, in several other studies (37, 38), it has been observed that the inhibitory effect of these compounds differs in magnitude depending on the cell type and concentration.

Little is known about the intracellular signals leading to PS externalization. Our results from the present and previous (16) studies strongly suggest that an alteration of SOCE is correlated with a reduced PS exposure. Indeed, Ca2+ entry inhibitors, SKF-96365 and miconazole, which inhibit store-operated Ca2+ channels, are also able to significantly reduce PS exposure. Ca2+ entry inhibitors also reduced prothrombinase activity in the supernatants, suggesting a Ca2+ dependence for microvesicle release. These inhibitors were deliberately used at low concentration to prevent artificial perturbation of the lipid organization in the plasma membrane, because this may happen in the presence of membrane-binding molecules (8).

After stimulation, HEL cells and microparticles were both strongly labeled by annexin VFITC, confirming that a major fraction of microparticles bore exposed PS (91 ± 2%). Similar results were obtained in platelets (10, 39, 40), red blood cells (41), monocytes (29), and endothelial cells (42). This suggests that most if not all shed vesicles express PS at their surface and may therefore disseminate membrane-associated procoagulant activity.

The actin microfilaments of the cytoskeleton form a complex network, providing the structural basis for simultaneous interactions between multiple cellular structures. For example, the actin-based cytoskeleton is involved in the control of ion channel activity across the plasma membrane of different cell types (43, 44). In the present study, CytD treatment inhibited A23187-induced Ca2+ responses and both Ca2+ release and entry evoked by TG. Similar observations have been reported in astrocytes after agonist stimulation, suggesting that disruption of microfilaments inhibits receptor/Gi-protein interaction (45). However, here we can exclude this hypothesis, because HEL cells were stimulated by two agents, A23187 and TG, involving distinct signaling pathways. It is likely that the cytoskeleton regulates Ca2+ signaling at different stages of Ca2+ release and SOCE. In addition, the results concerning the effect of CytD on Ca2+ release and/or Ca2+ entry are conflicting. Ribeiro et al. (46) and Patterson et al. (47) have observed that CytD did not block TG-induced Ca2+ entry in NIH 3T3 or smooth muscle cells, respectively. Other authors have observed that CytD did not alter the agonist-induced Ca2+ release in vascular endothelial cells, but Ca2+ entry was reduced (48). Moreover, in human platelets, Ca2+ stores released by TG were not affected by CytD, but SOCE was greatly reduced by cytoskeletal depolymerization (19). These discrepancies are probably related to a wide variability in the cytoskeletal intrinsic properties as a function of the cell type. Thus, the fact that cytoskeleton disruption attenuates A23187- and TG-induced Ca2+ release and entry in HEL cells indicates that cytoskeletal integrity or closely associated processes are essential for a normal coupling between Ca2+ stores and SOCE.

The role of cytoskeletal reorganization in PS exposure and microparticle formation has been emphasized by several groups who studied the relationships between both events in platelets. Inhibition of actin polymerization by CytD affected the shedding of membrane vesicles but had no effect on the redistribution of PS between the two leaflets of the platelet plasma membrane (49). Other authors (50-53) suggest that platelet cytoskeletal proteins are involved in the regulation of membrane lipid asymmetry. However, in the present study, we have observed that the diminution of Ca2+ influx across plasma membrane induced by CytD results in a significant reduction of PS exposure with almost no effect on microparticle shedding. Here, the partial inhibition suggests that the cytoskeleton plays a modulatory role rather than a mandatory one in this particular Ca2+ signaling pathway regulating PS exposure at the HEL cell surface. Recently, it has been observed that the actin-cytoskeleton is also able to modulate the uptake of membrane-derived microparticles by cells (54). These findings, when added to the results of the present study, suggest that cytoskeletal elements actively participate in the intercellular traffic of membrane proteins and, more generally, in the transcellular exchange of biological information.

HEL cells express platelet-specific membrane glycoproteins (26) and possess a strong ability of PS externalization following stimulation. Hence, such cells represent a useful model to investigate platelet properties. Among the latter, PS-dependent procoagulant response has an essential physiologic significance as demonstrated by the bleeding tendency in subjects with Scott syndrome, a genetic defect of PS transmembrane migration (55, 56). This study provides new insights into the control of PS transbilayer movements by both SOCE and cytoskeleton organization, and opens a new field of investigation of possible relationships with Ca2+-dependent scramblase (57), and ATP-binding cassette (ABC) transporters such as multidrug resistance P-glycoproteins (58), MRP1 (59), or ABC1 (60), suspected to act as lipid translocases.


    FOOTNOTES

* This work was supported in part by grants from the Institut National de la Santé et de la Recherche Médicale and the Université Louis Pasteur.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a doctoral fellowship from the Ministère de la Recherche et de la Technologie, France.

|| Supported by a fellowship from the Fondation pour la Recherche Médicale, France.

** To whom correspondence should be addressed: Institut d'Hématologie et d'Immunologie, Faculté de Médecine, 4 rue Kirschleger, 67085 Strasbourg, France. Tel.: 33-3-88-24-33-39; Fax: 33-3-88-25-58-83; E-mail: secr600@pharma.u-strasbg.fr.

Published, JBC Papers in Press, November 13, 2000, DOI 10.1074/jbc.M007924200


    ABBREVIATIONS

The abbreviations used are: [Ca2+]i, cytoplasmic free Ca2+ concentration; SOCE, store-operated Ca2+ entry; PS, phosphatidylserine; SKF-96365, 1-[beta -[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole hydrochloride; Fluo-3, fluo-3/acetoxymethyl ester; TG, thapsigargin; CytD, cytochalasin D; annexin VFITC, annexin V conjugated with fluorescein isothiocyanate; ABC, ATP-binding cassette; HEL cells, human erythroleukemia cells.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Putney, J. W., Jr, and Bird, G. S. (1993) Cell 75, 199-201[Medline] [Order article via Infotrieve]
2. Berridge, M. J. (1995) Biochem. J. 312, 1-11[Medline] [Order article via Infotrieve]
3. Parekh, A. B., and Penner, R. (1997) Physiol. Rev. 77, 901-930[Abstract/Free Full Text]
4. Berridge, M. J., Bootman, M. D., and Lipp, P. (1998) Nature 395, 645-648[CrossRef][Medline] [Order article via Infotrieve]
5. Sage, S. O., Reast, R., and Rink, T. J. (1990) Biochem. J. 265, 675-680[Medline] [Order article via Infotrieve]
6. Putney, J. W., Jr. (1991) Adv. Pharmacol. 22, 251-269[Medline] [Order article via Infotrieve]
7. Pasquet, J. M., Dachary-Prigent, J., and Nurden, A. T. (1996) Eur. J. Biochem. 239, 647-654[Abstract]
8. Devaux, P. F. (1991) Biochemistry 30, 1163-1173[Medline] [Order article via Infotrieve]
9. Bevers, E. M., Wiedmer, T., Comfurius, P., Shattil, S. J., Weiss, H. J., Zwaal, R. F. A., and Sims, P. J. (1992) Blood 79, 380-388[Abstract]
10. Dachary-Prigent, J., Pasquet, J. M., Freyssinet, J. M., and Nurden, A. T. (1995) Biochemistry 34, 11625-11634[Medline] [Order article via Infotrieve]
11. Zwaal, R. F. A., and Schroit, A. J. (1997) Blood 89, 1121-1132[Free Full Text]
12. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson, P. M. (1992) J. Immunol. 148, 2207-2216[Abstract/Free Full Text]
13. Comfurius, P., Senden, J. M. G., Tilly, R. H. J., Schroit, A. J., Bevers, E. M., and Zwaal, R. F. A. (1990) Biochim. Biophys. Acta 1026, 153-160[Medline] [Order article via Infotrieve]
14. Hampton, M. B., Vanags, D. M., Pörn-Ares, M. I., and Orrenius, S. (1996) FEBS Lett. 399, 277-282[CrossRef][Medline] [Order article via Infotrieve]
15. Williamson, P., Bevers, E. M., Smeets, E. F., Comfurius, P., Schlegel, R. A., and Zwaal, R. F. A. (1995) Biochemistry 34, 10448-10455[Medline] [Order article via Infotrieve]
16. Martínez, M. C., Martin, S., Toti, F., Fressinaud, E., Dachary-Prigent, J., Meyer, D., and Freyssinet, J. M. (1999) Biochemistry 38, 10092-10098[CrossRef][Medline] [Order article via Infotrieve]
17. Rosado, J. A., and Sage, S. O. (2000) J. Physiol. 526, 221-229[Abstract/Free Full Text]
18. Putney, J. W., Jr. (1999) Cell 99, 5-8[Medline] [Order article via Infotrieve]
19. Rosado, J. A., Jenner, S., and Sage, S. O. (2000) J. Biol. Chem. 275, 7527-7533[Abstract/Free Full Text]
20. Fujimoto, T., Fujimura, K., and Kuramoto, A. (1991) J. Biol. Chem. 266, 16370-16375[Abstract/Free Full Text]
21. Vu, T. K. H., Hung, D. T., Wheaton, V. I., and Coughlin, S. R. (1991) Cell 64, 1057-1068[Medline] [Order article via Infotrieve]
22. Gidon-Jeangirard, C., Solito, E., Hofmann, A., Russo-Marie, F., Freyssinet, J. M., and Martínez, M. C. (1999) Biochem. Biophys. Res. Commun. 265, 709-715[CrossRef][Medline] [Order article via Infotrieve]
23. Kunzelmann-Marche, C., Satta, N., Toti, F., Zhang, Y., Nawroth, P. P., Morrissey, J. H., and Freyssinet, J. M. (2000) Thromb. Haemostasis 83, 282-289[Medline] [Order article via Infotrieve]
24. Vittet, D., Mathieu, M. N., Launay, J. M., and Chevillard, C. (1992) Exp. Hematol. 20, 1129-1134[Medline] [Order article via Infotrieve]
25. Jennings, L. K., Slack, S. M., Wall, C. D., and Mondoro, T. H. (1996) Blood Cells Mol. Dis. 22, 23-35[CrossRef][Medline] [Order article via Infotrieve]
26. Catani, L., Gugliotta, L., Motta, M., Tazzari, P., Baravelli, S., and Tura, S. (1998) Haematologica 83, 385-391[Medline] [Order article via Infotrieve]
27. Connor, J., Bucana, C., Fidler, I. J., and Schroit, A. J. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 3184-3188[Abstract]
28. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450[Abstract]
29. Satta, N., Toti, F., Feugeas, O., Bohbot, A., Dachary-Prigent, J., Eschwege, V., Hedman, H., and Freyssinet, J. M. (1994) J. Immunol. 153, 3245-3255[Abstract/Free Full Text]
30. Merritt, J. E., Armstrong, W. P., Benham, C. D., Hallam, T. J., Jacob, R., Jaxa-Chamiec, A., Leigh, B. K., McCarthy, S. A., Moores, K. E., and Rink, T. J. (1990) Biochem. J. 271, 515-522[Medline] [Order article via Infotrieve]
31. Aussel, C., Marhaba, R., Pelassy, C., and Breittmayer, J. P. (1996) Biochem. J. 313, 909-913[Medline] [Order article via Infotrieve]
32. Koch, B. D., Faurot, G. F., Kopanitsa, M. V., and Swinney, D. C. (1994) Biochem. J. 302, 187-190[Medline] [Order article via Infotrieve]
33. Petersheim, M., and Sun, J. (1989) Biophys. J. 55, 631-636[Abstract]
34. Andree, H. A. M., Reutelingsperger, C. P. M., Hauptmann, R., Hemker, H. C., Hermens, W. T., and Willems, G. M. (1990) J. Biol. Chem. 265, 4923-4928[Abstract/Free Full Text]
35. Fox, J. E. B., and Phillips, D. R. (1981) Nature 292, 650-652[Medline] [Order article via Infotrieve]
36. Sargeant, P., and Sage, S. O. (1994) Pharmacol. Ther. 64, 395-443[CrossRef][Medline] [Order article via Infotrieve]
37. Jan, C. R., and Tseng, C. J. (1999) Life Sci. 65, 2513-2522[CrossRef][Medline] [Order article via Infotrieve]
38. Jayadev, S., Petranka, J. G., Cheran, S. K., Biermann, J. A., Barrett, J. C., and Murphy, E. (1999) J. Biol. Chem. 274, 8261-8268[Abstract/Free Full Text]
39. Dachary-Prigent, J., Freyssinet, J. M., Pasquet, J. M., Carron, J. C., and Nurden, A. T. (1993) Blood 81, 2554-2565[Abstract]
40. Heijnen, H. F. G., Schiel, A. E., Fijnheer, R., Geuze, H. J., and Sixma, J. J. (1999) Blood 11, 3791-3799
41. Dressler, V., Haest, C. W., Plasa, G., Deuticke, B., and Erusalimsky, J. D. (1984) Biochim. Biophys. Acta 775, 189-196[Medline] [Order article via Infotrieve]
42. Hamilton, K. K., Hattori, R., Esmon, C. T., and Sims, P. J. (1990) J. Biol. Chem. 265, 3809-3814[Abstract/Free Full Text]
43. Schwiebert, E. M., Mills, J. W., and Stanton, B. A. (1994) J. Biol. Chem. 269, 7081-7089[Abstract/Free Full Text]
44. Maximov, A. V., Vedernikova, E. A., Hinssen, H., Khaitlina, S. Y., and Negulyaev, Y. A. (1997) FEBS Lett. 412, 94-96[CrossRef][Medline] [Order article via Infotrieve]
45. Sergeeva, M., Ubl, J. J., and Reiser, G. (2000) Neuroscience 97, 765-769[CrossRef][Medline] [Order article via Infotrieve]
46. Ribeiro, C. M., Reece, J., and Putney, J. W., Jr. (1997) J. Biol. Chem. 272, 26555-26561[Abstract/Free Full Text]
47. Patterson, R. L., vanRossum, D. B., and Gill, D. L. (1999) Cell 98, 487-499[Medline] [Order article via Infotrieve]
48. Holda, J. R., and Blatter, L. A. (1997) FEBS Lett. 403, 191-196[CrossRef][Medline] [Order article via Infotrieve]
49. Gaffet, P., Bettache, N., and Bienvenüe, A. (1995) Eur. J. Cell Biol. 67, 336-345[Medline] [Order article via Infotrieve]
50. Comfurius, P., Bevers, E. M., and Zwaal, R. F. (1985) Biochim. Biophys. Acta 815, 143-148[Medline] [Order article via Infotrieve]
51. Verhallen, P. F., Bevers, E. M., Comfurius, P., and Zwaal, R. F. (1987) Biochim. Biophys. Acta 903, 206-217[Medline] [Order article via Infotrieve]
52. Fox, J. E. B., Austin, C. D., Boyles, J. K., and Steffen, P. K. (1990) J. Cell Biol. 111, 483-493[Abstract]
53. Yano, Y., Kambayashi, J., Shiba, E., Sakon, M., Oiki, E., Fukuda, K., Kawasaki, T., and Mori, T. (1994) Biochem. J. 299, 303-308[Medline] [Order article via Infotrieve]
54. Mack, M., Kleinschmidt, A., Bruhl, H., Klier, C., Nelson, P. J., Cihak, J., Plachy, J., Stangassinger, M., Erfle, V., and Schlondorff, D. (2000) Nat. Med. 6, 769-775[CrossRef][Medline] [Order article via Infotrieve]
55. Weiss, H. J. (1994) Semin. Hematol. 31, 312-319[Medline] [Order article via Infotrieve]
56. Toti, F., Satta, N., Fressinaud, E., Meyer, D., and Freyssinet, J. M. (1996) Blood 87, 1409-1415[Abstract/Free Full Text]
57. Zhou, Q., Zhao, J., Stout, J. G., Luhm, R. A., Wiedmer, T., and Sims, P. J. (1997) J. Biol. Chem. 272, 18240-18244[Abstract/Free Full Text]
58. Helvoort, A. v., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., and Meer, G. v. (1996) Cell 87, 507-517[Medline] [Order article via Infotrieve]
59. Filipeanu, C. M., Nelemansa, A., Veldmanb, R. J., deZeeuwa, D., and Kokb, J. W. (2000) FEBS Lett. 474, 107-110[CrossRef][Medline] [Order article via Infotrieve]
60. Hamon, Y., Broccardo, C., Chambenoit, O., Luciani, M. F., Toti, F., Chaslin, S., Freyssinet, J. M., Devaux, P. F., McNeish, J., Marguet, D., and Chimini, G. (2000) Nat. Cell Biol. 2, 399-406[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.